Adaptimmune Therapeutics (ADAP)
0.52
-0.02 (-3.70%)
At close: Mar 03, 2025, 3:59 PM
0.51
-2.46%
After-hours: Mar 03, 2025, 04:00 PM EST
Adaptimmune Therapeutics Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -1.4 | -1.42 | -3.7 | -5.9 | -0.92 | -5.86 | -8.38 | -4.01 | -30.38 | -63.89 | -31.88 | n/a |
| PEG Ratio | 0.03 | n/a | -0.28 | 0.19 | -0.02 | -0.25 | 0.36 | -0.06 | -0.22 | 1.27 | n/a | n/a |
| PS Ratio | 2.65 | 8.67 | 95.02 | 194.01 | 112.26 | 9.41 | 15.53 | 20.19 | 61.18 | 1.34K | n/a | n/a |
| PB Ratio | 4.04 | 2.87 | 2.84 | 2.25 | 1.02 | 2.27 | 2.89 | 1.73 | 2.53 | 336.74 | -125.17 | n/a |
| P/FCF Ratio | -1.09 | -1.37 | 299.93 | -13.59 | -1.09 | -5.13 | -7.41 | -4.7 | -17.33 | 22.68 | -34.05 | n/a |
| P/OCF Ratio | -1.13 | -1.66 | 54.46 | -14.33 | -1.12 | -5.36 | -10.82 | -5.95 | -20.04 | 21.80 | -34.75 | n/a |
| OCF/S Ratio | -2.34 | -5.22 | 1.74 | -13.54 | -100.27 | -1.75 | -1.44 | -3.39 | -3.05 | 61.58 | n/a | n/a |
| Debt / Equity Ratio | 0.64 | 0.28 | 0.12 | 0.07 | 0.21 | 0.55 | 0.61 | n/a | n/a | n/a | -0.71 | -12.23 |
| Quick Ratio | 2.85 | 3.94 | 6.63 | 10.14 | 3.47 | 9.41 | 3.05 | 4.91 | 11.02 | 1.02 | 0.40 | 0.95 |
| Current Ratio | 2.85 | 3.96 | 6.64 | 10.19 | 3.51 | 9.46 | 3.10 | 4.94 | 11.03 | 1.02 | 0.40 | 0.95 |
| Asset Turnover | 0.21 | 0.08 | 0.01 | 0.01 | 0.01 | 0.22 | 0.13 | 0.06 | 0.04 | 0.01 | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | -219.06 | -36.17 | n/a | n/a | -2.11K | -1.54K | n/a |
| Return on Equity (ROE) | -2.88 | -2.02 | -0.77 | -0.38 | -1.11 | -0.39 | -0.35 | -0.43 | -0.08 | -5.27 | 3.93 | n/a |
| Return on Assets (ROA) | -0.4 | -0.5 | -0.34 | -0.29 | -0.76 | -0.35 | -0.25 | -0.31 | -0.07 | -0.23 | -4.68 | n/a |
| Return on Capital (ROIC) | -0.66 | -0.62 | -0.4 | -0.32 | -0.95 | -0.33 | -0.39 | -0.37 | -0.08 | -5.96 | 4.34 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 83.65% | -370.48% | -1.71K% | -2.21K% | -8.59K% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | n/a | n/a |
| Net Profit Margin | -188.9% | -609.46% | -2.57K% | -3.29K% | -12.23K% | -160.51% | -185.39% | -504.15% | -201.36% | -2.1K% | n/a | n/a |
| Pretax Profit Margin | -186.68% | -600.26% | -2.56K% | -3.28K% | -12.2K% | -159.68% | -184.2% | -497.87% | -221% | -2.38K% | n/a | n/a |
| Operating Profit Margin | -228.99% | -603.97% | -2.64K% | -3.37K% | -12.46K% | -138.42% | -213.2% | -512.74% | -215.17% | -2.38K% | n/a | n/a |
| FCF Margin | -241.8% | -631.76% | 31.68% | -1.43K% | -10.3K% | -183.34% | -209.68% | -429.31% | -352.99% | 5.92K% | n/a | n/a |
| EBITDA Margin | -212.67% | -573.13% | -2.53K% | -3.18K% | -11.74K% | -125.29% | -198.87% | -489.6% | -221.68% | -3.95K% | n/a | n/a |